IDR 2260.0
(-3.42%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -38.49 Billion IDR | 12.89% |
2022 | -44.18 Billion IDR | -126.73% |
2021 | 165.3 Billion IDR | 1240.21% |
2020 | -14.49 Billion IDR | 80.87% |
2019 | -75.77 Billion IDR | 20.59% |
2018 | -95.41 Billion IDR | 5.39% |
2017 | -100.85 Billion IDR | -3.73% |
2016 | -97.22 Billion IDR | 26.44% |
2015 | -132.17 Billion IDR | -31.7% |
2014 | -100.36 Billion IDR | -82.07% |
2013 | -55.12 Billion IDR | -1263.52% |
2012 | 4.73 Billion IDR | 0.69% |
2011 | 4.7 Billion IDR | -21.65% |
2010 | 6 Billion IDR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | 4.89 Billion IDR | 3.09% |
2024 Q1 | 4.75 Billion IDR | 319.42% |
2023 Q4 | 1.13 Billion IDR | -51.37% |
2023 Q2 | -28.1 Billion IDR | -103.39% |
2023 FY | -38.49 Billion IDR | 12.89% |
2023 Q3 | 2.33 Billion IDR | 108.29% |
2023 Q1 | -13.81 Billion IDR | -75.77% |
2022 Q2 | -32.84 Billion IDR | -470.53% |
2022 Q4 | -7.86 Billion IDR | 36.63% |
2022 FY | -44.18 Billion IDR | -126.73% |
2022 Q1 | 8.86 Billion IDR | 115.63% |
2022 Q3 | -12.4 Billion IDR | 62.23% |
2021 Q1 | 68.14 Billion IDR | 70.3% |
2021 FY | 165.3 Billion IDR | 1240.21% |
2021 Q3 | 66.84 Billion IDR | -23.19% |
2021 Q4 | -56.71 Billion IDR | -184.84% |
2021 Q2 | 87.03 Billion IDR | 27.72% |
2020 Q4 | 40.01 Billion IDR | 366.25% |
2020 Q2 | -53.55 Billion IDR | -468.49% |
2020 Q3 | 8.58 Billion IDR | 116.02% |
2020 Q1 | -9.42 Billion IDR | 87.14% |
2020 FY | -14.49 Billion IDR | 80.87% |
2019 Q2 | -10.73 Billion IDR | -367.94% |
2019 FY | -75.77 Billion IDR | 20.59% |
2019 Q3 | 4.31 Billion IDR | 140.18% |
2019 Q4 | -73.25 Billion IDR | -1798.22% |
2019 Q1 | 4 Billion IDR | 110.56% |
2018 Q3 | -10.51 Billion IDR | 53.52% |
2018 Q2 | -22.62 Billion IDR | 7.08% |
2018 Q1 | -24.35 Billion IDR | 54.3% |
2018 FY | -95.41 Billion IDR | 5.39% |
2018 Q4 | -37.92 Billion IDR | -260.58% |
2017 Q2 | -17.54 Billion IDR | 28.42% |
2017 Q1 | -24.5 Billion IDR | -3596.69% |
2017 FY | -100.85 Billion IDR | -3.73% |
2017 Q4 | -53.28 Billion IDR | -865.94% |
2017 Q3 | -5.51 Billion IDR | 68.55% |
2016 Q2 | -40.53 Billion IDR | -180.54% |
2016 FY | -97.22 Billion IDR | 26.44% |
2016 Q4 | 700.77 Million IDR | 101.63% |
2016 Q3 | -42.94 Billion IDR | -5.94% |
2016 Q1 | -14.44 Billion IDR | 77.64% |
2015 Q3 | -27.12 Billion IDR | -26.74% |
2015 Q2 | -21.4 Billion IDR | -12.42% |
2015 Q1 | -19.03 Billion IDR | 27.37% |
2015 FY | -132.17 Billion IDR | -31.7% |
2015 Q4 | -64.6 Billion IDR | -138.15% |
2014 Q1 | -16.53 Billion IDR | 17.29% |
2014 FY | -100.36 Billion IDR | -82.07% |
2014 Q4 | -26.21 Billion IDR | 32.81% |
2014 Q3 | -39.01 Billion IDR | -109.77% |
2014 Q2 | -18.59 Billion IDR | -12.45% |
2013 Q1 | -7.09 Billion IDR | -2254.22% |
2013 Q2 | -7.41 Billion IDR | -4.58% |
2013 Q4 | -19.99 Billion IDR | 3.03% |
2013 Q3 | -20.62 Billion IDR | -178.08% |
2013 FY | -55.12 Billion IDR | -1263.52% |
2012 Q2 | 991.03 Million IDR | -42.89% |
2012 Q1 | 1.73 Billion IDR | 88.71% |
2012 FY | 4.73 Billion IDR | 0.69% |
2012 Q3 | 1.68 Billion IDR | 69.73% |
2012 Q4 | 329.13 Million IDR | -80.43% |
2011 Q3 | 1.23 Billion IDR | 0.44% |
2011 Q2 | 1.23 Billion IDR | -6.25% |
2011 Q4 | 919.54 Million IDR | -25.73% |
2011 FY | 4.7 Billion IDR | -21.65% |
2011 Q1 | 1.31 Billion IDR | 0.0% |
2010 FY | 6 Billion IDR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
PT Bundamedik Tbk | 7.46 Billion IDR | 615.873% |
PT Metro Healthcare Indonesia Tbk | -110.91 Billion IDR | 65.299% |
PT Medikaloka Hermina Tbk | 437.34 Billion IDR | 108.801% |
PT Mitra Keluarga Karyasehat Tbk | 916.13 Billion IDR | 104.201% |
PT Murni Sadar Tbk | -12.83 Billion IDR | -199.958% |
PT Famon Awal Bros Sedaya Tbk | 216.97 Billion IDR | 117.739% |
PT Royal Prima Tbk | -2.74 Billion IDR | -1301.419% |
PT Kedoya Adyaraya Tbk | 25.18 Billion IDR | 252.806% |
PT Sarana Meditama Metropolitan Tbk | 12.25 Billion IDR | 414.148% |
PT Siloam International Hospitals Tbk | 1211.28 Billion IDR | 103.178% |